Top Industry News

Novartis has broken ground on a new biomedical research center in San Diego, California. The facility represents another milestone in the company’s $23-billion US-based investments first announced in April 2025.  Once operational in…

Sanofi has completed its $2.2-billion acquisition of Dynavax Technologies, a vaccines company. The deal was announced in January 2026.  Dynavax’s key product is its adult hepatitis B vaccine, Heplisav-B, which is marketed in the US and is differentiated by a two-dose regimen…

Eli Lilly and Company has agreed to acquire Orna Therapeutics, a bio/pharmaceutical company dedicated to engineering immune cells in vivo, for $2.4 billion.  Orna is advancing a class of therapeutics using engineered circular RNA paired…

Sanofi has appointed Belén Garijo, currently Chair and CEO of Merck KGaA, as CEO, effective April 29, 2026. She will succeed Paul Hudson, the company’s current CEO, who will remain CEO until February 17, 2026. Olivier Charmeil, currently Executive Vice President, General…

The latest from CDMOs, CMOs, and suppliers featuring Fujifilm Biotechnologies & Rentschler Biopharma.   Biologics Manufacturing * Fujifilm Biotechnologies Opens $546-M UK Biomanufacturing Expansion Appointments * Rentschler Biopharma Appoints New COO  Biologics Manufacturing  Fujifilm Biotechnologies Opens…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Eli Lilly and Company, Takeda, Moderna, Alkermes, and CSL. Highlights below.   For the latest news roundup on small and Emerging Pharma…

The latest from small and Emerging Pharma companies featuring the European Life Sciences Coalition, Madrigal Pharmaceuticals, and Ribocure.  For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs.  * European Life…

Eli Lilly and Company has announced an investment of $3.5 billion in a new manufacturing facility in Pennsylvania. The expansion is part of the company’s multi-year $50-billion investments in US capital expansion…

The US Food and Drug Administration (FDA) has announced that it is accepting requests to participate in the FDA PreCheck pilot program, a new program the agency says is designed to…

The Indian government has announced the launch of Biopharma Shakti, a national initiative with an investment of $1.1 billion over five years, aimed at strengthening India’s end-to-end ecosystem for biologics and biosimilars.  …